Medindia
Medindia LOGIN REGISTER
Advertisement

GC Pharma Reports Full Year 2018 Results

Tuesday, February 12, 2019 General News
Advertisement

Key Figures(K-IFRS)

Full Year 2018(KRW billion)

Growth(1)

Total revenues

1334.9

+3.6%

Operating income

50.2

(44.4)%

EBITDA

90.4

(28.8) %

(1) Results and percentages to the full financial year 2017

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close